Welcome to our dedicated page for Patterson Cos news (Ticker: PDCO), a resource for investors and traders seeking the latest updates and insights on Patterson Cos stock.
Patterson Companies, Inc. (Nasdaq: PDCO) is a specialty distributor focused on the dental and animal health markets, connecting customers in North America and the U.K. to products, technologies, services and business solutions. The PDCO news feed highlights company announcements, financial updates and corporate developments that shape the outlook for this health care distributor.
News about Patterson Companies includes earnings releases that discuss segment performance in dental and animal health, internal sales trends and value-added services. These updates provide detail on how the dental and animal health segments are performing and how factors such as market conditions or external events affect the business. Company communications also cover strategic reviews, guidance updates and capital allocation decisions.
Corporate transaction news is a key theme for PDCO. Patterson has announced a definitive agreement to be acquired by Patient Square Capital, and subsequent updates describe the progress of this transaction, including the expiration of a go-shop period and shareholder approval of the acquisition. Index provider announcements also note that Patterson will be removed from the S&P SmallCap 600 index in connection with this transaction.
The PDCO news stream features information on strategic relationships and technology initiatives, such as Patterson Dental’s extended relationship with PDS Health and integrations between Patterson Dental’s practice management software and third-party platforms. For investors and observers following Patterson Companies, this news page brings together developments on its operations, financial performance and the planned transition from a public company to private ownership under Patient Square Capital.
Patterson Companies reported fiscal Q3 2021 net sales of $1.55 billion, reflecting a 6.5% year-over-year increase. Net income surged to $48.8 million ($0.50 per share), up from $23.2 million ($0.24 per share) in Q3 2020. Adjusted net income rose 25.3% to $55.8 million ($0.58 per share). The Dental segment generated $648.9 million in sales, while Animal Health reached $894.3 million. Despite strong performance, the company refrained from giving Q4 guidance due to COVID-19 uncertainties.
Patterson Companies (Nasdaq: PDCO) will hold its fiscal 2021 third-quarter conference call on March 3, 2021, at 9 a.m. CT (10 a.m. ET). The earnings release will be available that morning before market opening. Interested investors can access the live webcast through the investor relations section on www.PattersonCompanies.com. A replay of the conference call will be accessible starting at 11 a.m. CT on the same day until March 10, 2021, at 10:59 p.m. CT. The company connects dental and animal health customers in North America and the U.K. with innovative solutions.
Patterson Companies, a leading distributor in animal and oral health markets, will present virtually at the 2021 J.P. Morgan Healthcare Conference on January 12, 2021, at 5:20 p.m. Eastern Time. This conference unites key players from the healthcare industry, innovative tech firms, and investors. Following the presentation, interested parties can download the session from pattersoncompanies.com in the Investor Relations section. Patterson focuses on providing cutting-edge products and solutions to ensure customer success.
On December 15, 2020, Patterson Companies declared a quarterly cash dividend of $0.26 per share, payable around January 29, 2021. Shareholders of record as of the close of business on January 15, 2021 will receive this payment. Patterson Companies connects dental and animal health markets in North America and the U.K. with essential products and services that promote operational success.
Patterson Companies, Inc. (Nasdaq: PDCO) reported a robust fiscal second quarter ending October 24, 2020, with consolidated net sales of $1.55 billion, a 9.5 percent year-over-year increase. Net income surged to $54.1 million or $0.56 per diluted share, compared to a net loss of $33.1 million in the previous year. Adjusted net income increased 62 percent to $61.1 million. Key segments, Dental and Animal Health, contributed significantly with net sales of $631.7 million and $914.2 million, respectively. However, due to ongoing pandemic uncertainties, the company is withholding fiscal 2021 guidance.
Patterson Companies (Nasdaq: PDCO) will hold its fiscal 2021 second-quarter conference call on December 2, 2020, at 9 a.m. CT. The earnings release will be made available before the market opens that day. A replay of the call will be accessible from 11 a.m. CT on the same day until December 9, 2020. Interested parties can listen in by calling (800) 585-8367 with Conference ID 1517668. Patterson Companies offers a comprehensive portfolio and services for dental and animal health sectors in North America and the U.K.